Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record.

Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study

Open access
Sapisochin, G., de Lope, C. Rodríguez, Gastaca, M., de Urbina, J. Ortiz, López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., Pons, J. A., Parrilla, P., González-Diéguez, M. L., Rodriguez, M., Otero, A., Vazquez, M. A., Zozaya, G., Herrero, J. I., Antolin, G. Sanchez, Perez, B., Ciria, R., Rufian, S., Fundora, Y., Ferron, J. A., Guiberteau, A., Blanco, G., Varona, M. A., Barrera, M. A., Suarez, M. A., Santoyo, J., Bruix, J., Charco, R.·2014·Annals of Surgery

Abstract

OBJECTIVE: To evaluate the outcome of patients with hepatocellular-cholangiocarcinoma (HCC-CC) or intrahepatic cholangiocarcinoma (I-CC) on pathological examination after liver transplantation for HCC. BACKGROUND: Information on the outcome of cirrhotic patients undergoing a transplant for HCC and with a diagnosis of HCC-CC or I-CC by pathological study is limited. METHODS: Multicenter, retrospective, matched cohort 1:2 study. STUDY GROUP: 42 patients undergoing a transplant for HCC and with a diagnosis of HCC-CC or I-CC by pathological study; and control group: 84 patients with a diagnosis of HCC. I-CC subgroup: 27 patients compared with 54 controls; HCC-CC subgroup: 15 patients compared with 30 controls. Patients were also divided according to the preoperative tumor size and number: uninodular tumors 2 cm or smaller and multinodular or uninodular tumors 2 cm or larger. Median follow-up: 51 (range, 3-142) months. RESULTS: The 1-, 3-, and 5-year actuarial survival rate differed between the study and control groups (83%, 70%, and 60% vs 99%, 94%, and 89%, respectively; P < 0.001). Differences were found in 1-, 3-, and 5-year actuarial survival rates between the I-CC subgroup and their controls (78%, 66%, and 51% vs 100%, 98%, and 93%; P < 0.001), but no differences were observed between the HCC-CC subgroup and their controls (93%, 78%, and 78% vs 97%, 86%, and 86%; P = 0.9). Patients with uninodular tumors 2 cm or smaller in the study and control groups had similar 1-, 3-, and 5-year survival rate (92%, 83%, 62% vs 100%, 80%, 80%; P = 0.4). In contrast, patients in the study group with multinodular or uninodular tumors larger than 2 cm had worse 1-, 3-, and 5-year survival rates than their controls (80%, 66%, and 61% vs 99%, 96%, and 90%; P < 0.001). CONCLUSIONS: Patients with HCC-CC have similar survival to patients undergoing a transplant for HCC. Preoperative diagnosis of HCC-CC should not prompt the exclusion of these patients from transplant option.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000494

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
Sapisochin, G., de Lope, C. R., Gastaca, M., de Urbina, J. O., López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., Pons, J. A., Parrilla, P., González-Diéguez, M. L., Rodriguez, M., Otero, A., Vazquez, M. A., Zozaya, G., Herrero, J. I., Antolin, G. S., Perez, B., Ciria, R., Rufian, S., Fundora, Y., Ferron, J. A., Guiberteau, A., Blanco, G., Varona, M. A., Barrera, M. A., Suarez, M. A., Santoyo, J., Bruix, J., & Charco, R.
Venue
Annals of Surgery
Published
2014-05
Volume
259
Issue
5
Pages
944-952
ISSN
0003-4932 (ISSN-L)
OpenAlex
W1974749071
Cited by
185
References
0
FWCI
7.04
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study. https://app.cochat.ai/papers/10.1097/sla.0000000000000494
The paper
Sapisochin, G., de Lope, C. R., Gastaca, M., de Urbina, J. O., López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., Pons, J. A., Parrilla, P., González-Diéguez, M. L., Rodriguez, M., Otero, A., Vazquez, M. A., Zozaya, G., Herrero, J. I., Antolin, G. S., . . . Charco, R. (2014). Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000494

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.